These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 97384

  • 1. trans-2,3b,4,5,7,8b,9,10-Octahydronaphtho[1,2-c:5,6-c']dipyrazole, a new orally active antiallergic compound.
    Vítolo MJ, Márquez VE, Hurtado I.
    J Med Chem; 1978 Jul; 21(7):692-4. PubMed ID: 97384
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of allergic reactions by a new antiallergic drug, LC-6 (trans-2,3b,4,5,7,8b,9,10-octahydronaphthol[1,2-c:5,6-c'] dipyrazole). I. Inhibition of the rat reaginic passive cutaneous anaphylaxis.
    Hurtado I, Márquez VE, Vítolo MJ.
    Int Arch Allergy Appl Immunol; 1978 Jul; 57(6):507-13. PubMed ID: 28295
    [Abstract] [Full Text] [Related]

  • 3. Preparation and evaluation of a soluble derivative of the antiallergic compound trans-2, 3b, 4, 5, 7, 8b, 9, 10-octahydronaphtho [1, 2-c:5, 6-c'] dipyrazole (LC-6).
    Hurtado I, Urbina C, Suárez C, Beyer B, Magro AM.
    Int J Immunopharmacol; 1985 Jul; 7(5):635-8. PubMed ID: 2864322
    [Abstract] [Full Text] [Related]

  • 4. The orally active antiallergic compound, LC-6 (trans-2,3b,4,5,7,8b,9,10-octahydronaphtho[1,2-c:5,6-C] dipyrazole) inhibits the arachidonate lipoxygenase enzyme.
    Magro AM, Hurtado I.
    J Immunopharmacol; 1983 Jul; 5(3):191-202. PubMed ID: 6197487
    [Abstract] [Full Text] [Related]

  • 5. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP, Srimal RC, Avasthi K, Garg N, Chandra T, Bhakuni DS.
    Indian J Exp Biol; 1995 Jan; 33(1):38-40. PubMed ID: 9135673
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
    Musser JH, Jones H, Sciortino S, Bailey K, Coutts SM, Khandwala A, Sonnino-Goldman P, Leibowitz M, Wolf P, Neiss ES.
    J Med Chem; 1985 Sep; 28(9):1255-9. PubMed ID: 2411926
    [Abstract] [Full Text] [Related]

  • 7. Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity.
    Althuis TH, Moore PF, Hess HJ.
    J Med Chem; 1979 Jan; 22(1):44-8. PubMed ID: 106118
    [Abstract] [Full Text] [Related]

  • 8. Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents.
    Sircar JC, Capiris T, Kesten SJ, Herzig DJ.
    J Med Chem; 1981 Jun; 24(6):735-42. PubMed ID: 6788957
    [No Abstract] [Full Text] [Related]

  • 9. LC-6 inhibition of the rat skin reactions is due to mediator release inhibitor and not to mediator antagonism.
    Hurtado I, Urbina C.
    Acta Cient Venez; 1983 Jun; 34(1):44-7. PubMed ID: 6424369
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and study of the potential antiallergic activity of some pyrazole derivatives.
    Di Parsia MT, Suárez C, Vítolo MJ, Márquez VE, Beyer B, Urbina C, Hurtado I.
    J Med Chem; 1981 Jan; 24(1):117-9. PubMed ID: 7205868
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR, Fullarton JR, Skidmore IF, Thompson LE, Vardey CJ, Wheeldon A.
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of rat passive cutaneous anaphylaxis by 3-(tetrazol-5-yl)quinolines.
    Erickson EH, Hainline CF, Lenon LS, Matson CJ, Rice TK, Swingle KE, Van Winkle M.
    J Med Chem; 1979 Jul; 22(7):816-23. PubMed ID: 109613
    [Abstract] [Full Text] [Related]

  • 13. Antiallergic activity of tetracyclic derivatives of quinoline-2-carboxylic acid. 2. Some benzothienoquinolinecarboxylic acids.
    Wade JJ, Erickson EH, Hegel RF, Lappi LR, Rice TK.
    J Med Chem; 1978 Sep; 21(9):941-8. PubMed ID: 102797
    [Abstract] [Full Text] [Related]

  • 14. N-(4-Isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents.
    Chiarino D, Grancini G, Frigeni V, Biasini I, Carenzi A.
    J Med Chem; 1991 Feb; 34(2):600-5. PubMed ID: 1899891
    [Abstract] [Full Text] [Related]

  • 15. [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine maleate, desonide and disodium cromoglycate after cutaneous administration].
    Tarayre JP, Aliaga M, Villanova G, Barbara M, Bru M, Caillol V, Lauressergues H.
    J Pharmacol; 1984 Feb; 15(1):37-51. PubMed ID: 6425568
    [Abstract] [Full Text] [Related]

  • 16. The effect of predosage with disodium cromoglycate (DSCG) on the dose-related inhibition of rat passive cutaneous anaphylaxis by DSCG.
    Riley PA, Sheard P, Clarke AJ, Orr TS.
    Life Sci; 1975 Sep 01; 17(5):793-802. PubMed ID: 813078
    [No Abstract] [Full Text] [Related]

  • 17. Antiallergic activity of 2-phenyl-8-azapurin-6-ones.
    Broughton BJ, Chaplen P, Knowles P, Lunt E, Marshall SM, Pain DL, Wooldridge KR.
    J Med Chem; 1975 Nov 01; 18(11):1117-22. PubMed ID: 809582
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione.
    Spicer BA, Ross JW, Smith H.
    Clin Exp Immunol; 1975 Sep 01; 21(3):419-29. PubMed ID: 812623
    [Abstract] [Full Text] [Related]

  • 19. Studies on antiallergic agents. I. Synthesis and antiallergic activity of novel pyrazine derivatives.
    Makino E, Iwasaki N, Yagi N, Ohashi T, Kato H, Ito Y, Azuma H.
    Chem Pharm Bull (Tokyo); 1990 Jan 01; 38(1):201-7. PubMed ID: 1692517
    [Abstract] [Full Text] [Related]

  • 20. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R, Kazimierczak W.
    Arch Immunol Ther Exp (Warsz); 1982 Jan 01; 30(5-6):333-9. PubMed ID: 6135406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.